共 57 条
[1]
Raghu G(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-824
[2]
Collard HR(2011)Clinical course and prediction of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 431-440
[3]
Egan JJ(2019)Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets Int J Mol Sci 20 593-182
[4]
Ley B(2017)Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines Am J Manag Care 23 176-1491
[5]
Collard HR(2020)Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging Ann Rheum Dis 79 1485-1415
[6]
King TE(2020)The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients Rheumatology 59 1407-e194
[7]
Ballester B(2021)Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study Lancet Rheumatol 3 e185-133
[8]
Milara J(2022)Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study J Nucl Med 63 127-3716
[9]
Cortijo J(2022)[ Eur J Nucl Med Mol Imaging 49 3705-207
[10]
Sharif R(2023)Ga]Ga-FAPI-46 PET for noninvasive detection of pulmonary fibrosis disease activity Radiology 306 201-7878